South Korea
· Delayed Price · Currency is KRW PHARMARESEARCH BIO Company Description
PHARMA RESEARCH BIO Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products worldwide.
The company offers ReNTox injection for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged between 18 and 65.
It is also developing Clostridium Botulinum Toxin type A, which is in Phase I clinical study for indications, including dynamic equinus foot deformity, upper limb spasticity, blepharospasm, etc. The company was formerly known as BIOCND Inc. and changed its name to PHARMA RESEARCH BIO Co., Ltd. in March 2018.
PHARMA RESEARCH BIO Co., Ltd. was founded in 2009 and is headquartered in Gangneung, South Korea.
| Country | South Korea |
| Founded | 2009 |
| Industry | Pharmaceutical Preparations |
Contact Details
Address: 641-3, Saimdang-ro Gangneung South Korea | |
| Phone | 82 3 3655 7560 |
| Website | pr-bio.co.kr |
Stock Details
| Ticker Symbol | 217950 |
| Exchange | Korea New Exchange |
| Reporting Currency | KRW |
| SIC Code | 2834 |